Fig. 5
Plots of tumor vs. Vigil levels, for 9 ovarian cancer patients selected from the Vigil Phase IIB trial, for cTMB (A), cNEO (B) and ITH (C). Patient 103_0009 in which no clonal variants were detected, is represented by red shaded circle.
Fig. 5 | Scientific Reports
